 | • レポートコード：D0FB0617889 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：製薬・医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Site License | ￥700,000 (USD5,000) | ▷ お問い合わせ |
| Global Site License | ￥840,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| デュシェンヌ型筋ジストロフィー薬の世界市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。「デュシェンヌ型筋ジストロフィー薬の世界市場」レポートはデュシェンヌ型筋ジストロフィー薬の世界市場に関する専門的で詳細な調査結果です。デュシェンヌ型筋ジストロフィー薬の市場環境、市場動向、産業チェーン、価格、貿易動向、企業情報、世界主要地域の市場規模（日本、アメリカ、中国、インド、アジア、ヨーロッパなど）などの情報を掲載しています。 ・市場環境 ・市場動向分析 ・産業チェーン分析 ・貿易動向分析（デュシェンヌ型筋ジストロフィー薬の輸出・輸入） ・デュシェンヌ型筋ジストロフィー薬の北米市場2013-2018（アメリカ、カナダ、メキシコ） ・デュシェンヌ型筋ジストロフィー薬の南米市場2013-2018（ブラジル、アルゼンチン、チリなど） ・デュシェンヌ型筋ジストロフィー薬のアジア市場2013-2018（日本、中国、インド、韓国、東南アジアなど） ・デュシェンヌ型筋ジストロフィー薬のヨーロッパ市場2013-2018（ドイツ、フランス、イギリス、ロシアなど） ・デュシェンヌ型筋ジストロフィー薬の中東・アフリカ市場2013-2018（エジプト、南アフリカ、トルコなど） ・デュシェンヌ型筋ジストロフィー薬の世界市場サマリー2013-2018（供給、需要、競合状況） ・デュシェンヌ型筋ジストロフィー薬の市場規模予測2019-2023（供給予測、需要予測） ・主要企業分析（Akashi Therapeutics Inc、Antisense Therapeutics Ltd、Beech Tree Labs Inc、Biogen Inc、Bioleaders Corp、BioMarin Pharmaceutical Inc、Biophytis SAS、Capricor Therapeutics Inc、Catabasis Pharmaceuticals ） |
The global market size of Duchenne Muscular Dystrophy Drugs is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.
Global Duchenne Muscular Dystrophy Drugs Market Report 2019 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Duchenne Muscular Dystrophy Drugs industry. The key insights of the report:
1.The report provides key statistics on the market status of the Duchenne Muscular Dystrophy Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report estimates 2019-2024 market development trends of Duchenne Muscular Dystrophy Drugs industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report makes some important proposals for a new project of Duchenne Muscular Dystrophy Drugs Industry before evaluating its feasibility.
There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.
For competitor segment, the report includes global key players of Duchenne Muscular Dystrophy Drugs as well as some small players. At least 9 companies are included:
* Akashi Therapeutics Inc
* Antisense Therapeutics Ltd
* Beech Tree Labs Inc
* Biogen Inc
* Bioleaders Corp
* BioMarin Pharmaceutical Inc
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Duchenne Muscular Dystrophy Drugs market
* Development & Drug Target
* Mechanism of Action (MoA)
* Route of Administration (RoA)
* Molecule Type
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Hospitals and Clinics
* Medical Laboratories
* Others
For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report covers following regions:
* North America
* South America
* Asia & Pacific
* Europe
* MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.
レポート目次Table of Content
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Methodology
3.2.1 Primary Sources
3.2.2 Secondary Sources
3.2.3 Assumptions
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Duchenne Muscular Dystrophy Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Duchenne Muscular Dystrophy Drugs by Region
8.2 Import of Duchenne Muscular Dystrophy Drugs by Region
8.3 Balance of Trade
Chapter 9 Historical and Current Duchenne Muscular Dystrophy Drugs in North America (2013-2018)
9.1 Duchenne Muscular Dystrophy Drugs Supply
9.2 Duchenne Muscular Dystrophy Drugs Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 US
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Historical and Current Duchenne Muscular Dystrophy Drugs in South America (2013-2018)
10.1 Duchenne Muscular Dystrophy Drugs Supply
10.2 Duchenne Muscular Dystrophy Drugs Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
Chapter 11 Historical and Current Duchenne Muscular Dystrophy Drugs in Asia & Pacific (2013-2018)
11.1 Duchenne Muscular Dystrophy Drugs Supply
11.2 Duchenne Muscular Dystrophy Drugs Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 ASEAN
11.5.6 Australia
Chapter 12 Historical and Current Duchenne Muscular Dystrophy Drugs in Europe (2013-2018)
12.1 Duchenne Muscular Dystrophy Drugs Supply
12.2 Duchenne Muscular Dystrophy Drugs Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 UK
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
Chapter 13 Historical and Current Duchenne Muscular Dystrophy Drugs in MEA (2013-2018)
13.1 Duchenne Muscular Dystrophy Drugs Supply
13.2 Duchenne Muscular Dystrophy Drugs Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Iran
13.5.3 Israel
13.5.4 South Africa
13.5.5 GCC
13.5.6 Turkey
Chapter 14 Summary for Global Duchenne Muscular Dystrophy Drugs (2013-2018)
14.1 Duchenne Muscular Dystrophy Drugs Supply
14.2 Duchenne Muscular Dystrophy Drugs Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price
Chapter 15 Global Duchenne Muscular Dystrophy Drugs Forecast (2019-2023)
15.1 Duchenne Muscular Dystrophy Drugs Supply Forecast
15.2 Duchenne Muscular Dystrophy Drugs Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast
Chapter 16 Analysis of Global Key Vendors
16.1 Akashi Therapeutics Inc
16.1.1 Company Profile
16.1.2 Main Business and Duchenne Muscular Dystrophy Drugs Information
16.1.3 SWOT Analysis of Akashi Therapeutics Inc
16.1.4 Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
16.2 Antisense Therapeutics Ltd
16.2.1 Company Profile
16.2.2 Main Business and Duchenne Muscular Dystrophy Drugs Information
16.2.3 SWOT Analysis of Antisense Therapeutics Ltd
16.2.4 Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
16.3 Beech Tree Labs Inc
16.3.1 Company Profile
16.3.2 Main Business and Duchenne Muscular Dystrophy Drugs Information
16.3.3 SWOT Analysis of Beech Tree Labs Inc
16.3.4 Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
16.4 Biogen Inc
16.4.1 Company Profile
16.4.2 Main Business and Duchenne Muscular Dystrophy Drugs Information
16.4.3 SWOT Analysis of Biogen Inc
16.4.4 Biogen Inc Duchenne Muscular Dystrophy Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
16.5 Bioleaders Corp
16.5.1 Company Profile
16.5.2 Main Business and Duchenne Muscular Dystrophy Drugs Information
16.5.3 SWOT Analysis of Bioleaders Corp
16.5.4 Bioleaders Corp Duchenne Muscular Dystrophy Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
16.6 BioMarin Pharmaceutical Inc
16.6.1 Company Profile
16.6.2 Main Business and Duchenne Muscular Dystrophy Drugs Information
16.6.3 SWOT Analysis of BioMarin Pharmaceutical Inc
16.6.4 BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
16.7 Biophytis SAS
16.7.1 Company Profile
16.7.2 Main Business and Duchenne Muscular Dystrophy Drugs Information
16.7.3 SWOT Analysis of Biophytis SAS
16.7.4 Biophytis SAS Duchenne Muscular Dystrophy Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
……
……
Tables and Figures
Table Abbreviation and Acronyms List
Table Research Scope of Duchenne Muscular Dystrophy Drugs Report
Table Primary Sources of Duchenne Muscular Dystrophy Drugs Report
Table Secondary Sources of Duchenne Muscular Dystrophy Drugs Report
Table Major Assumptions of Duchenne Muscular Dystrophy Drugs Report
Figure Duchenne Muscular Dystrophy Drugs Picture
Table Duchenne Muscular Dystrophy Drugs Classification
Table Duchenne Muscular Dystrophy Drugs Applications List
Table Drivers of Duchenne Muscular Dystrophy Drugs Market
Table Restraints of Duchenne Muscular Dystrophy Drugs Market
Table Opportunities of Duchenne Muscular Dystrophy Drugs Market
Table Threats of Duchenne Muscular Dystrophy Drugs Market
Table Raw Materials Suppliers List
Table Different Production Methods of Duchenne Muscular Dystrophy Drugs
Table Cost Structure Analysis of Duchenne Muscular Dystrophy Drugs
Table Key End Users List
Table Latest News of Duchenne Muscular Dystrophy Drugs Market
Table Merger and Acquisition List
Table Planned/Future Project of Duchenne Muscular Dystrophy Drugs Market
Table Policy of Duchenne Muscular Dystrophy Drugs Market
Table 2014-2024 Regional Export of Duchenne Muscular Dystrophy Drugs
Table 2014-2024 Regional Import of Duchenne Muscular Dystrophy Drugs
Table 2014-2024 Regional Trade Balance
Figure 2014-2024 Regional Trade Balance
Table 2014-2024 North America Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Figure 2014-2024 North America Duchenne Muscular Dystrophy Drugs Market Size (M USD) and CAGR
Figure 2014-2024 North America Duchenne Muscular Dystrophy Drugs Market Volume (Tons) and CAGR
Table 2014-2024 North America Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Application
Table 2014-2019 North America Duchenne Muscular Dystrophy Drugs Key Players Sales (Tons) List
Table 2014-2019 North America Duchenne Muscular Dystrophy Drugs Key Players Market Share List
Table 2014-2024 North America Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Type
Table 2014-2019 North America Duchenne Muscular Dystrophy Drugs Price (USD/Ton) List by Type
Table 2014-2024 US Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 US Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Canada Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Canada Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Mexico Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Mexico Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 South America Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Figure 2014-2024 South America Duchenne Muscular Dystrophy Drugs Market Size (M USD) and CAGR
Figure 2014-2024 South America Duchenne Muscular Dystrophy Drugs Market Volume (Tons) and CAGR
Table 2014-2024 South America Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Application
Table 2014-2019 South America Duchenne Muscular Dystrophy Drugs Key Players Sales (Tons) List
Table 2014-2019 South America Duchenne Muscular Dystrophy Drugs Key Players Market Share List
Table 2014-2024 South America Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Type
Table 2014-2019 South America Duchenne Muscular Dystrophy Drugs Price (USD/Ton) List by Type
Table 2014-2024 Brazil Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Brazil Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Argentina Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Argentina Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Chile Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Chile Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Peru Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Peru Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Asia & Pacific Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Figure 2014-2024 Asia & Pacific Duchenne Muscular Dystrophy Drugs Market Size (M USD) and CAGR
Figure 2014-2024 Asia & Pacific Duchenne Muscular Dystrophy Drugs Market Volume (Tons) and CAGR
Table 2014-2024 Asia & Pacific Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Application
Table 2014-2019 Asia & Pacific Duchenne Muscular Dystrophy Drugs Key Players Sales (Tons) List
Table 2014-2019 Asia & Pacific Duchenne Muscular Dystrophy Drugs Key Players Market Share List
Table 2014-2024 Asia & Pacific Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Type
Table 2014-2019 Asia & Pacific Duchenne Muscular Dystrophy Drugs Price (USD/Ton) List by Type
Table 2014-2024 China Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 China Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 India Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 India Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Japan Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Japan Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 South Korea Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 South Korea Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 ASEAN Duchenne Muscular Dystrophy Drugs Market Size (M USD) List
Table 2014-2024 ASEAN Duchenne Muscular Dystrophy Drugs Market Volume (Tons) List
Table 2014-2024 ASEAN Duchenne Muscular Dystrophy Drugs Import (Tons) List
Table 2014-2024 ASEAN Duchenne Muscular Dystrophy Drugs Export (Tons) List
Table 2014-2024 Australia Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Australia Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Europe Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Figure 2014-2024 Europe Duchenne Muscular Dystrophy Drugs Market Size (M USD) and CAGR
Figure 2014-2024 Europe Duchenne Muscular Dystrophy Drugs Market Volume (Tons) and CAGR
Table 2014-2024 Europe Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Application
Table 2014-2019 Europe Duchenne Muscular Dystrophy Drugs Key Players Sales (Tons) List
Table 2014-2019 Europe Duchenne Muscular Dystrophy Drugs Key Players Market Share List
Table 2014-2024 Europe Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Type
Table 2014-2019 Europe Duchenne Muscular Dystrophy Drugs Price (USD/Ton) List by Type
Table 2014-2024 Germany Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Germany Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 France Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 France Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 UK Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 UK Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Italy Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Italy Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Spain Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Spain Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Belgium Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Belgium Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Netherlands Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Netherlands Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Austria Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Austria Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Poland Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Poland Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Russia Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Russia Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 MEA Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Figure 2014-2024 MEA Duchenne Muscular Dystrophy Drugs Market Size (M USD) and CAGR
Figure 2014-2024 MEA Duchenne Muscular Dystrophy Drugs Market Volume (Tons) and CAGR
Table 2014-2024 MEA Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Application
Table 2014-2019 MEA Duchenne Muscular Dystrophy Drugs Key Players Sales (Tons) List
Table 2014-2019 MEA Duchenne Muscular Dystrophy Drugs Key Players Market Share List
Table 2014-2024 MEA Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Type
Table 2014-2019 MEA Duchenne Muscular Dystrophy Drugs Price (USD/Ton) List by Type
Table 2014-2024 Egypt Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Egypt Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Iran Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Iran Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Israel Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Israel Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 South Africa Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 South Africa Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 GCC Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 GCC Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2024 Turkey Duchenne Muscular Dystrophy Drugs Market Size (M USD) and Market Volume (Tons) List
Table 2014-2024 Turkey Duchenne Muscular Dystrophy Drugs Import & Export (Tons) List
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Market Size (M USD) List by Region
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Market Size Share List by Region
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Market Volume (Tons) List by Region
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Market Volume Share List by Region
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Application
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Demand Market Share List by Application
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Capacity (Tons) List
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Key Vendors Capacity Share List
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production (Tons) List
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production Share List
Figure 2014-2019 Global Duchenne Muscular Dystrophy Drugs Capacity Production and Growth Rate
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production Value (M USD) List
Figure 2014-2019 Global Duchenne Muscular Dystrophy Drugs Production Value (M USD) and Growth Rate
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production Value Share List
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Type
Table 2014-2019 Global Duchenne Muscular Dystrophy Drugs Demand Market Share List by Type
Table 2014-2019 Regional Duchenne Muscular Dystrophy Drugs Price (USD/Ton) List
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Market Size (M USD) List by Region
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Market Size Share List by Region
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Market Volume (Tons) List by Region
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Market Volume Share List by Region
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Application
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Demand Market Share List by Application
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Capacity (Tons) List
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Key Vendors Capacity Share List
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production (Tons) List
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production Share List
Figure 2019-2024 Global Duchenne Muscular Dystrophy Drugs Capacity Production and Growth Rate
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production Value (M USD) List
Figure 2019-2024 Global Duchenne Muscular Dystrophy Drugs Production Value (M USD) and Growth Rate
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Key Vendors Production Value Share List
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Demand (Tons) List by Type
Table 2019-2024 Global Duchenne Muscular Dystrophy Drugs Demand Market Share List by Type
Table 2019-2024 Regional Duchenne Muscular Dystrophy Drugs Price (USD/Ton) List
Table Akashi Therapeutics Inc Information List
Table SWOT Analysis of Akashi Therapeutics Inc
Table 2014-2019 Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Product Capacity Production (Tons) Price Cost (USD/Ton) Production Value (M USD) List
Figure 2014-2019 Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Capacity Production (Tons) and Growth Rate
Figure 2014-2019 Akashi Therapeutics Inc Duchenne Muscular Dystrophy Drugs Market Share
Table Antisense Therapeutics Ltd Information List
Table SWOT Analysis of Antisense Therapeutics Ltd
Table 2014-2019 Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Product Capacity Production (Tons) Price Cost (USD/Ton) Production Value (M USD) List
Figure 2014-2019 Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Capacity Production (Tons) and Growth Rate
Figure 2014-2019 Antisense Therapeutics Ltd Duchenne Muscular Dystrophy Drugs Market Share
Table Beech Tree Labs Inc Information List
Table SWOT Analysis of Beech Tree Labs Inc
Table 2014-2019 Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Product Capacity Production (Tons) Price Cost (USD/Ton) Production Value (M USD) List
Figure 2014-2019 Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Capacity Production (Tons) and Growth Rate
Figure 2014-2019 Beech Tree Labs Inc Duchenne Muscular Dystrophy Drugs Market Share
Table Biogen Inc Information List
Table SWOT Analysis of Biogen Inc
Table 2014-2019 Biogen Inc Duchenne Muscular Dystrophy Drugs Product Capacity Production (Tons) Price Cost (USD/Ton) Production Value (M USD) List
Figure 2014-2019 Biogen Inc Duchenne Muscular Dystrophy Drugs Capacity Production (Tons) and Growth Rate
Figure 2014-2019 Biogen Inc Duchenne Muscular Dystrophy Drugs Market Share
Table Bioleaders Corp Information List
Table SWOT Analysis of Bioleaders Corp
Table 2014-2019 Bioleaders Corp Duchenne Muscular Dystrophy Drugs Product Capacity Production (Tons) Price Cost (USD/Ton) Production Value (M USD) List
Figure 2014-2019 Bioleaders Corp Duchenne Muscular Dystrophy Drugs Capacity Production (Tons) and Growth Rate
Figure 2014-2019 Bioleaders Corp Duchenne Muscular Dystrophy Drugs Market Share
Table BioMarin Pharmaceutical Inc Information List
Table SWOT Analysis of BioMarin Pharmaceutical Inc
Table 2014-2019 BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Product Capacity Production (Tons) Price Cost (USD/Ton) Production Value (M USD) List
Figure 2014-2019 BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Capacity Production (Tons) and Growth Rate
Figure 2014-2019 BioMarin Pharmaceutical Inc Duchenne Muscular Dystrophy Drugs Market Share
Table Biophytis SAS Information List
Table SWOT Analysis of Biophytis SAS
Table 2014-2019 Biophytis SAS Duchenne Muscular Dystrophy Drugs Product Capacity Production (Tons) Price Cost (USD/Ton) Production Value (M USD) List
Figure 2014-2019 Biophytis SAS Duchenne Muscular Dystrophy Drugs Capacity Production (Tons) and Growth Rate
Figure 2014-2019 Biophytis SAS Duchenne Muscular Dystrophy Drugs Market Share
……
……
ベッカー型筋ジストロフィー薬の世界市場：市場規模・シェア・価格・動向・予測 The global market size of Becker Muscular Dystrophy Drug is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. Global Becker Muscular Dystrophy Drug Market Report 2019 - Market Size, Share, Price, Trend…- 脊髄性筋萎縮症の世界市場：市場規模・シェア・価格・動向・予測 The global market size of Spinal Muscular Atrophy Medicine is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. Global Spinal Muscular Atrophy Medicine Market Report 2019 - Market Size, Share, Price, T…
- 脊髄性筋萎縮症（SMA）治療の世界市場：市場規模・シェア・価格・動向・予測 The global market size of Spinal Muscular Atrophy (SMA) Treatment is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024. Global Spinal Muscular Atrophy (SMA) Treatment Market Report 2019 - Market Size, S…